IRVINE, Calif.--(BUSINESS WIRE)--Two new diabetes companies, Prodo Laboratories, Inc. and Invenio Institute, announced their launch at the Rachmiel Levine Diabetes and Obesity Symposium held last week in Long Beach, CA. Prodo Laboratories, Inc., a privately held biopharmaceutical company located in Irvine, CA, will provide primary human islets as a research service to corporate investigators and will offer islet research tissue culture media, reagents, and factors to diabetes researchers. In addition to pursuing its own research programs, it will also provide small company incubator opportunities in diabetes. Invenio Institute, a California public benefit company also in Irvine, CA, is a new diabetes research institute that will begin providing human islets to academic researchers as it builds its diabetes research program.
